Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- Check3 days agoChange DetectedThe page revision label updates to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. The new screenshot shows the updated version label with no visible changes to study content.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, a minor metadata change with no impact on page content or usability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page metadata.SummaryDifference0.0%

- Check97 days agoChange DetectedExpanded and revised the Locations section by adding state site listings (CA, CO, FL, IL, MA, MO, NY, NC, OH, OK, TN, TX, WI) and removing prior state entries. This changes which study sites are listed and where participants can enroll.SummaryDifference1%

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.